Adam Horblitt is a Cardiology physician. OpenAlex indexes 17 publications with 428 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
251 W Main St Ste 6
Branford, CT 064054047
Telephone
203-315-5300Provider last certified this registry record 4 Aug 2022.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202528 payments
- Novartis Pharmaceuticals CorporationProgram year202519 payments
- Novo Nordisk IncProgram year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
94.9%Beta blocker23.7%Metoprolol Succinate54%Carvedilol41%Metoprolol Tartrate5%Part D<11 patientsStatin22.8%Rosuvastatin Calcium52%Atorvastatin Calcium42%Pravastatin Sodium7%Part D<11 patients+ 12 more classes in this area
Blood & clotting
2.9%Factor Xa inhibitor2.1%Eliquis100%Part D≥16 patientsP2Y12 inhibitor0.8%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
2.2%SGLT2 inhibitor1.4%Farxiga100%Part D<11 patientsPotassium supplement0.7%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Amyloid Imaging2022
- SYNTHETIC ANGIOTENSIN II EXACERBATION OF SEPTIC MYOCARDITIS, CAUTIOUS UTILIZATION OF NOVEL VASOPRESSOR PHARMACEUTICALS
Journal of the American College of Cardiology
2019 - A CASE OF TAKOTSUBO CARDIOMYOPATHY IN THE SETTING OF OBSTRUCTIVE CORONARY ARTERY DISEASE
Journal of the American College of Cardiology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”